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R
adical hysterectomy with pelvic lymphadenectomy is a widely accepted treatment for patients with Stage IB and IIA carcinoma of the uterine cervix. [1] [2] [3] [4] One of the most important critical determinants for prognosis is probably pelvic lymph node metastasis. The reported 5-year survival rate of patients with negative pelvic lymph nodes is approximately 90%, compared with 50 -65% for patients with positive lymph nodes. [1] [2] [3] [4] [5] [6] It is therefore not surprising that efforts made to 
MATERIALS AND METHODS
The medical records of 271 patients with Stage IB and IIA cervical carcinoma who were treated with a Wernoted. The sites of recurrence were categorized as pelvic (recurrences involving the central pelvic region, theim-Okabayashi radical hysterectomy and a complete pelvic lymphadenectomy were retrospectively such as the vagina, bladder and rectum, as well as those involving the pelvic sidewall) and distant (recurreviewed. Staging was done according to guidelines of the International Federation of Gynecology and Obrences outside the pelvis). Except for one distant recurrence, all recurrences were histologically confirmed. stetrics. Pathologic examination of the surgical specimens revealed negative pelvic lymph nodes in 218 pa-
The original pathology slides from the study group were reviewed and the following pathologic charactertients and positive lymph nodes in 53 patients. Twenty-two lymph node negative patients in whom istics evaluated: histologic tumor type, differentation grade, tumor diameter, depth of invasion measured in no residual tumor was found in the uterine specimen and whose biopsy slides were unavailable for review millimeters from the basement membrane, depth of invasion as a fraction of cervical stroma penetration were excluded from the analysis. Disease did not recur in any of these patients. The remaining 196 lymph by the tumor (calculated as the depth of invasion in millimeters divided by the distance from the tumor's node negative patients constituted the study group. From these patients a variety of clinical and pathologic surface to the fibromuscular parametrial border), parametrium infiltration, vaginal involvement, tumor data, follow-up data, and recurrence patterns were growth pattern (exophytic or endophytic), tumor stromal border (pushing or tentacular), vascular space inwith recurrence. Some of these factors were found to vasion, host response (quality and quantity of the strobe interrelated. For example, a significant correlation mal inflammatory infiltrate and the degree of deswas found between tumor size and depth of invasion moplastic reaction of the stroma), and the degree of (r Å 0.63, P Å 0.001) and between tumor size and the necrosis within the tumor.
fraction of cervical stroma penetration by the tumor Comparisons of groups were made using the chi-(r Å 0.56, P Å 0.001). square test, Fisher's exact test, and Pearson's correla-
The results of the univariate analysis with respect tion coefficient (r). Disease free interval (DFI) was estito DFI are presented in Table 1 (significant factors) mated by the Kaplan-Meier method. 13 The log rank and Table 2 (nonsignificant factors). Significant factors test was used to determine whether differences existed included adenocarcinoma, tumor size, depth of invabetween the groups. Patients who died of intercurrent sion in millimeters, and depth of invasion as a fraction disease or who were lost to follow-up were censored at of cervical penetration by the tumor. the time of last known follow-up. Multivariate analysis When all factors were included in a Cox regression was performed using a Cox proportional hazards reanalysis for DFI, adenocarcinoma (P Å 0.003), fraction gression analysis in a forward stepwise manner; a P of cervical stroma penetration (P Å 0.01), and stromal value of 0.05 was the criteria for inclusion.
inflammatory cell infiltrate (P Å 0.04) were the only independent factors that were predictive of recurrence (Table 3) . In the Cox model, the hazard increased by
RESULTS
The average age of the 196 patients was 44 years an estimated factor of 4.6 (95% confidence interval [CI]: 3.6 -5.9) per one-third increase in the fraction of (range, 22 -77 years). There were 158 patients with squamous cell carcinoma, 37 with adenocarcinoma cervical stroma penetration. Patients with adenocarcinoma had an estimated 2.3 (95% CI: 1.3 -4.0) times (including 4 with adenosquamous carcinoma), and 1 with undifferentiated carcinoma. Adjuvant pelvic rahigher hazard than patients with squamous cell carcinoma. For the stromal inflammatory cell infiltrate facdiotherapy (40 -50 gray in 4 -5 weeks) was administered to 26 patients for the following reasons: parametor, the hazard ratio was 2.5 (95% CI: 1.0 -6.2) when there was an extensive response compared with a light trium infiltration (N Å 17), spill during surgery (N Å 1), close or involved margins (N Å 4), or a combination or moderate response. Based on the hazard ratios, the following risk factors were defined: adenocarcinoma, of factors (N Å 4). The median duration of follow-up for censored patients was 68 months. The estimated 5-extensive infiltrate stroma response, and cervical stroma penetration ¢2/3. The 5-year DFI for patients year DFI for the entire group was 92%. Fifteen patients experienced recurrent disease (7.7%): 9 developed a without any risk factor was 97% (standard error [SE]: 2.5%), whereas for patients with one risk factor and pelvic recurrence (including 3 patients with a concomitant distant recurrence) and 6 a distant recurrence.
patients with more than one risk factor, the DFIs were 98% (SE: 1.7%) and 81% (SE: 5.3%), respectively ( Fig.  Among the 26 patients who received adjuvant radiotherapy, 1 developed a pelvic recurrence and 1 a dis-1). According to these figures, risk groups for DFI were formed as shown in of invasion in absolute millimeters and as a fraction To determine which pathologic factors influenced of cervical stroma penetration. In the current multilocal tumor control, a Cox regression analysis for pelvariate analysis, all these of three factors were invic recurrence was performed using all previously cluded. Only for the fraction of cervical stroma penementioned pathologic factors. Adenocarcinoma (P Å tration was evidence found of an association with re-0.03), fraction of cervical penetration (P Å 0.03), and currence. This suggests that the prognostic tentacular tumor stromal border (P Å 0.02) proved to significance of tumor size and depth of invasion in be independent factors. millimeters, as observed in the univariate analysis, arose only in their association with the fraction of cer-DISCUSSION vical stroma penetration. A possible explanation for In the current study, we attempted to identify risk facthese findings is that as a tumor involves a greater tors for tumor recurrence among a group of 196 Stage fraction of the cervical stroma, the risk for metastatic IB and IIA cervical carcinoma patients with negative spread increases because the tumor gains more access pelvic lymph nodes after radical hysterectomy. In multo larger lymphatic trunks and blood vessels that insert tivariate analysis, the prognostic significance of a large at the periphery of the cervix. Because the fraction of number of surgical pathologic factors was determined.
cervical penetration depends not only on the depth of In this analysis, adenocarcinoma was an indepeninvasion but also on the thickness of the cervix, this dent risk factor for recurrence. In the literature, varyratio is different in an atrophic cervix than in a large, ing results have been reported with respect to the premenopausal, multiparous cervix, given an equal prognostic significance of tumor histology. In some depth of tumor invasion. 22 In a recent multivariate multivariate studies, adenocarcoma was found to be analysis in which tumor size and cervical penetration a poor prognostic factor, 14,15 whereas in other studies, tumor histology had no influence on survival. penetration was an independent prognostic factor, were unable to confirm this. We feel that the prognostic significance of this factor needs further clarificawhereas tumor size and pelvic lymph node metastases were not. 22 The same authors performed the analysis tion. Based on these three independent prognostic facon the group of lymph node negative patients only, and again cervical penetration had more prognostic tors, we were able to define a subgroup of 55 high risk patients that comprised 11 of the 15 recurrences. significance than tumor size. 20 Delgado et al. demonstrated in a large study of the Gynecologic Oncology Because the factors adenocarcinoma and fraction of cervical stromal penetration were also significantly reGroup of the National Cancer Institute (GOG) that the risk of pelvic lymph node metastases for patients with lated to locoregional tumor control, this subgroup included 5 of the 6 isolated pelvic recurrences. Stage I disease was more strongly associated with depth of invasion in fractional thirds (as fractions of
In the current study, the proportion of pelvic recurrences was 60% (9/15). Table 6 presents a review cervical penetration) than depth of invasion in absolute millimeters. 23 In another GOG report on Stage IB of the literature addressing the patterns of recurrence in surgically treated patients with early stage cervical sqaumous carcinoma, it was found that the risk of recurrence in patients with tumors invading the outer carcinoma and negative pelvic lymph nodes. The collated data showed that in this category of patients, third of the cervix was very high and not influenced by depth of invasion in absolute millimeters. 21 In our more than two-thirds of the recurrences were located in the pelvic region. This raised the question of opinion, these observations warrant further investigation to determine if depth of invasion as a fraction of whether local tumor control in such patients might be improved with adjuvant pelvic radiotherapy. Although cervical penetration is a more critical determinant for prognosis than depth of invasion in absolute millimethe effect of adjuvant radiotherapy has never been determined in a prospective randomized trial, Kinney et ters or tumor size.
The degree of stromal inflammatory cell infiltrate al. provided data strongly suggesting that it is highly effective in preventing pelvic recurrences. 37 In their was also a significant prognostic factor for recurrence in this study, although its association was less promatched control study on lymph node positive patients, a 40% reduction in pelvic recurrences was obnounced (P Å 0.04). In the literature, only a few reports have investigated the prognostic significance of this served with adjuvant pelvic radiotherapy. In nonmatched retrospective studies, a similar observation factor in early stage cervical carcinoma. 24 Some authors noticed a better outcome when there was a prewas made. 38, 39 In a retrospective, nonmatched study, Remy et al. dominance of eosinophilic leukocytes. 25 
